This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Leif Nørkskov-Lauritsen: Innovator in Aprotinin Variants
Introduction
Leif Nørkskov-Lauritsen is a notable inventor based in Tappernøje, Denmark. He has made significant contributions to the field of biochemistry, particularly through his work on aprotinin variants. His innovative approach has led to advancements in enzyme-inhibitory, immunological, and pharmacokinetic properties.
Latest Patents
Leif holds a patent for "Aprotinin variants having improved properties." This invention focuses on the development of aprotinin variants that exhibit enhanced enzyme-inhibitory, immunological, and pharmacokinetic characteristics. The patent represents a significant step forward in the application of aprotinin in various medical fields.
Career Highlights
Throughout his career, Leif has been associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Leif has worked alongside notable colleagues such as Werner Schröder and Søren Bjørn. Their combined expertise has fostered an environment of innovation and discovery, leading to advancements in their respective areas of research.
Conclusion
Leif Nørkskov-Lauritsen's contributions to the field of biochemistry, particularly through his patent on aprotinin variants, highlight his role as an influential inventor. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile